These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25175281)

  • 21. Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis.
    Bandapalli OR; Ehrmann F; Ehemann V; Gaida M; Macher-Goeppinger S; Wente M; Schirmacher P; Brand K
    Cytokine; 2012 Jan; 57(1):46-53. PubMed ID: 22129625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
    Delaney CE; Weagant BT; Addison CL
    Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.
    Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W
    Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis.
    Matsumoto G; Hirohata R; Hayashi K; Sugimoto Y; Kotani E; Shimabukuro J; Hirano T; Nakajima Y; Kawamata S; Mori H
    Biomaterials; 2014 Jan; 35(4):1326-33. PubMed ID: 24210874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2-mediated angiogenesis.
    Pan F; Yang W; Li W; Yang XY; Liu S; Li X; Zhao X; Ding H; Qin L; Pan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317708547. PubMed ID: 28714365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-κB.
    Suboj P; Babykutty S; Valiyaparambil Gopi DR; Nair RS; Srinivas P; Gopala S
    Eur J Pharm Sci; 2012 Apr; 45(5):581-91. PubMed ID: 22227305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity.
    Wickström SA; Alitalo K; Keski-Oja J
    J Biol Chem; 2003 Sep; 278(39):37895-901. PubMed ID: 12851410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
    Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
    Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation.
    Gordillo GM; Onat D; Stockinger M; Roy S; Atalay M; Beck FM; Sen CK
    Am J Physiol Cell Physiol; 2004 Oct; 287(4):C866-73. PubMed ID: 15163622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model.
    Wang Y; Lin M; Weng H; Wang X; Yang L; Liu F
    Am J Obstet Gynecol; 2014 Jun; 210(6):531.e1-8. PubMed ID: 24495669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposite effects of endostatin on different endothelial cells.
    Schmidt A; Addicks K; Bloch W
    Cancer Biol Ther; 2004 Nov; 3(11):1162-6; discussion 1167-8. PubMed ID: 15640622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiangiogenesis signals by endostatin.
    Shichiri M; Hirata Y
    FASEB J; 2001 Apr; 15(6):1044-53. PubMed ID: 11292666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
    Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
    FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells].
    Yang F; He YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):978-80. PubMed ID: 16864091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
    Neskey DM; Ambesi A; Pumiglia KM; McKeown-Longo PJ
    J Exp Clin Cancer Res; 2008 Nov; 27(1):61. PubMed ID: 18983664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The generation of endostatin is mediated by elastase.
    Wen W; Moses MA; Wiederschain D; Arbiser JL; Folkman J
    Cancer Res; 1999 Dec; 59(24):6052-6. PubMed ID: 10626789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
    Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
    Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.